Contraceptive Technology Update
RSSArticles
-
A Low-Dose Estrogen Capsule Examined as Possibility for Vaginal Atrophy
About 32 million postmenopausal women in the United States are affected by vulvar and vaginal atrophy, which can cause painful sexual activity and urination, as well as vaginal dryness, itching, and irritation. Recent data presented at ENDO 2016, the annual meeting of the Endocrine Society, suggests an investigational low-dose vaginal estrogen capsule may help relieve such symptoms.
-
Medicaid Pushes Forward on Family Planning
With the end of the Obama administration rapidly approaching, federal agencies have stepped up their efforts to finalize long-brewing regulations and guidance. CMS has been particularly active. In April 2016, the agency issued three documents that all have considerable importance for family planning services and providers under Medicaid.
-
Data Suggest Hormonal Therapy Doesn’t Increase VTE Risk in Women on Anticoagulant Therapy
Women on anticoagulant therapy can take estrogen-containing contraception or hormone therapy without an increased risk of blood clots or uterine bleeding, findings from a recent study suggest.
-
Update on Contraceptive Implant — What Family Planners Need to Know
The contraceptive implant Nexplanon (Merck, Whitehouse Station, NJ) offers top-tier effectiveness against unintended pregnancy. How can you identify appropriate candidates, present counseling tips on the contraceptive and noncontraceptive benefits, and recognize and treat side effects and rare complications?
-
Success with Teen Pregnancy Rate, But There Is More Work Left to Do
Just-published data indicate that births among Hispanic and black teens have dropped by almost half since 2006, which mirrors a substantial national decline. Births to all American teenagers have dropped more than 40% within the past decade.
-
Use Online Resources from ARHP for HPV Patient and Provider Education
The Association of Reproductive Health Professionals offers a wide range of online resources on the human papillomavirus to help clinicians stay current on prevention and treatment, as well as to provide education to their patients.
-
Online ‘Pop Quiz’ Might Help Predict Sexually Transmitted Infections in Young Women
Researchers at the Baltimore-based Johns Hopkins University say an online “pop quiz” they developed in 2009 shows promising accuracy in predicting sexually transmitted infections in young women, although not apparently in young men.
-
Can Providers Create an HPV-free Zone? Communication and Scheduling are Key
Once you administer that first shot of the human papillomavirus vaccine, what are you doing to ensure that patients receive all three doses?
-
Initiating Contraceptive Provision with Teens
Sexuality is a natural and important part of human growth for young people and a developmental milestone. Statistics from the 2013 Youth Risk Behavior Surveillance System show that 47% of students report they ever have had sex, yet only 19% of those teens reported using birth control pills, and 5% reported using the contraceptive shot, contraceptive vaginal ring, or a long-acting reversible contraceptive method (implant or intrauterine device), at last sex.
-
In Memoriam: Ward Cates Jr., MD, MPH
Ward Cates Jr., MD, MPH, one of the co-authors of Contraceptive Technology, died March 17, 2016, in Chapel Hill, NC. Cates was president emeritus and distinguished scientist at FHI 360, a global nonprofit human development organization based in Durham, NC.